Provided by Tiger Trade Technology Pte. Ltd.

Humacyte, Inc.

1.26
-0.0200-1.56%
Post-market: 1.270.0100+0.79%19:56 EST
Volume:3.36M
Turnover:4.30M
Market Cap:235.96M
PE:-4.88
High:1.31
Open:1.30
Low:1.25
Close:1.28
52wk High:6.77
52wk Low:1.09
Shares:187.27M
Float Shares:154.09M
Volume Ratio:0.94
T/O Rate:2.18%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.2583
EPS(LYR):-1.2551
ROE:-249.75%
ROA:-63.44%
PB:-49.67
PE(LYR):-1.00

Loading ...

Humacyte Prices $60 Million Oversubscribed Registered Direct Offering; Shares Tumble

MT Newswires Live
·
Oct 07

BRIEF-Humacyte Announces Pricing Of $60.0 Million Oversubscribed Registered Direct Offering

Reuters
·
Oct 07

Humacyte Says Symvess Real-World Data Show 87% Patency Rate, Zero Infections

MT Newswires Live
·
Oct 06

Humacyte announces publication of Symvess results in real-world combat

TIPRANKS
·
Oct 06

Humacyte Is Maintained at Buy by D. Boral Capital

Dow Jones
·
Sep 30

Humacyte Awarded New US Patent for Bioengineered Esophagus

MT Newswires Live
·
Sep 29

Binance will delist the NXPC/BNB and HUMA/BNB spot trading pairs

Blockbeats
·
Sep 17

Humacyte Is Maintained at Buy by D. Boral Capital

Dow Jones
·
Sep 15

BRIEF-Humacyte Inc Files For Mixed Shelf Of Up To $350 Million - SEC Filing

Reuters
·
Sep 13

Humacyte files $350M mixed securities shelf

TIPRANKS
·
Sep 13

Humacyte Inc Files for Mixed Shelf of up to $350 Mln - SEC Filing

THOMSON REUTERS
·
Sep 13

Humacyte Initiated at Overweight by Barclays

Dow Jones
·
Aug 28

Barclays Initiates Humacyte at Overweight With $3.50 Price Target

MT Newswires Live
·
Aug 27

Humacyte Inc. :  Barclays Initiates Coverage With Overweight Rating and Target Price $3.5

THOMSON REUTERS
·
Aug 27

Director Brady W. Dougan Reports Disposal of Common Shares of Humacyte Inc

Reuters
·
Aug 21

Humacyte Inc. CEO Laura E. Niklason Reports Disposal of Common Shares

Reuters
·
Aug 21

Humacyte Is Maintained at Buy by D. Boral Capital

Dow Jones
·
Aug 12

Humacyte Inc reports results for the quarter ended June 30 - Earnings Summary

Reuters
·
Aug 11

Humacyte Q2 Revenue USD 100 Thousand Vs. IBES Estimate USD 1 Million

Reuters
·
Aug 11

Humacyte Q2 EPS $(0.24) Misses $(0.16) Estimate, Sales $301.000K Miss $931.143K Estimate

Benzinga
·
Aug 11